In addition, the CD45− fraction from MCA205WT tumors in vivo also expressed higher levels of Nos2 at later stages of PD-1 blockade (Fig. 5g) with a trend towards higher NOS2 protein levels in mAb-treated tumor cells compared with isotype (Fig. 5h). The gene discussed is NOS2; the disease is neoplasm.